132 related articles for article (PubMed ID: 23466502)
21. Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).
Li Y; Eskelund AR; Zhou H; Budac DP; Sánchez C; Gulinello M
Int J Mol Sci; 2015 Jul; 16(7):15150-71. PubMed ID: 26151848
[TBL] [Abstract][Full Text] [Related]
22. The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus.
Tomita M; Khan RL; Blehm BH; Santoro TJ
Med Hypotheses; 2004; 62(3):325-35. PubMed ID: 14975498
[TBL] [Abstract][Full Text] [Related]
23. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
24. Behaviour of MRL mice: an animal model of disturbed behaviour in systemic autoimmune disease.
Szechtman H; Sakić B; Denburg JA
Lupus; 1997; 6(3):223-9. PubMed ID: 9104727
[TBL] [Abstract][Full Text] [Related]
25. Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice.
Maric D; Millward JM; Ballok DA; Szechtman H; Denburg JA; Barker JL; Sakic B
Brain Res; 2001 Nov; 920(1-2):183-93. PubMed ID: 11716824
[TBL] [Abstract][Full Text] [Related]
26. Altered olfactory function in the MRL model of CNS lupus.
Kapadia M; Stanojcic M; Earls AM; Pulapaka S; Lee J; Sakic B
Behav Brain Res; 2012 Oct; 234(2):303-11. PubMed ID: 22796602
[TBL] [Abstract][Full Text] [Related]
27. Taste responsiveness and diet preference in autoimmune MRL mice.
Ballok DA; Szechtman H; Sakic B
Behav Brain Res; 2003 Mar; 140(1-2):119-30. PubMed ID: 12644285
[TBL] [Abstract][Full Text] [Related]
28. Altered neurotransmission in brains of autoimmune mice: pharmacological and neurochemical evidence.
Sakic B; Lacosta S; Denburg JA; Szechtman H
J Neuroimmunol; 2002 Aug; 129(1-2):84-96. PubMed ID: 12161024
[TBL] [Abstract][Full Text] [Related]
29. Systemic lupus erythematosus and the brain: what mice are telling us.
Alexander JJ; Quigg RJ
Neurochem Int; 2007 Jan; 50(1):5-11. PubMed ID: 16989923
[TBL] [Abstract][Full Text] [Related]
30. Knocking out of CD38 accelerates development of a lupus-like disease in lpr mice.
Viegas MS; Silva T; Monteiro MM; do Carmo A; Martins TC
Rheumatology (Oxford); 2011 Sep; 50(9):1569-77. PubMed ID: 21586522
[TBL] [Abstract][Full Text] [Related]
31. Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus.
Sled JG; Spring S; van Eede M; Lerch JP; Ullal S; Sakic B
Arthritis Rheum; 2009 Jun; 60(6):1764-74. PubMed ID: 19479832
[TBL] [Abstract][Full Text] [Related]
32. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity.
Hirohata S; Hirose S; Miyamoto T
Arch Intern Med; 1985 Oct; 145(10):1843-6. PubMed ID: 3899036
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
35. Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.
Sakic B; Kirkham DL; Ballok DA; Mwanjewe J; Fearon IM; Macri J; Yu G; Sidor MM; Denburg JA; Szechtman H; Lau J; Ball AK; Doering LC
J Neuroimmunol; 2005 Dec; 169(1-2):68-85. PubMed ID: 16198428
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions.
Kelly MC; Denburg JA
J Rheumatol; 1987 Aug; 14(4):740-4. PubMed ID: 3668979
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
[TBL] [Abstract][Full Text] [Related]
38. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
[TBL] [Abstract][Full Text] [Related]
39. Genetic basis of murine lupus.
Santiago-Raber ML; Laporte C; Reininger L; Izui S
Autoimmun Rev; 2004 Jan; 3(1):33-9. PubMed ID: 14871647
[TBL] [Abstract][Full Text] [Related]
40. Evaluating fatigue in lupus-prone mice: preliminary assessments.
Meeks A; Larson SJ
Pharmacol Biochem Behav; 2012 Jan; 100(3):392-7. PubMed ID: 21989254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
